The most optimal biosignature identified in the present study was a five-marker signature comprising of IL-1β, IL-23, ECM-1, HCC1 and fibrinogen, which diagnosed TB disease with a sensitivity of 88.9% and specificity of 89.7%, regardless of HIV infection status. This evidence concerns the gene IL1B and HIV infectious disease.